4 (2 FURYL) 2,6 DIMETHYL 3,5 BIS N (PHENYL)CARBAMOYL 1,4 DIHYDROPYRIDINE;
4 (2 FURYL) 2,6 DIMETHYL 3,5 BIS N (PYRIDIN 2 YL)CARBAMOYL 1,4 DIHYDROPYRIDINE;
4 (2 IMIDAZOLYL) 2,6 DIMETHYL 3,5 BIS N (4 METHYLPHENYL)CARBAMOYL 1,4 DIHYDROPYRIDINE;
4 (2 IMIDAZOLYL) 2,6 DIMETHYL 3,5 BIS N (PHENYL)CARBAMOYL 1,4 DIHYDROPYRIDINE;
4 (2 IMIDAZOLYL) 2,6 DIMETHYL 3,5 BIS N (PYRIDIN 2 YL)CARBAMOYL 1,4 DIHYDROPYRIDINE;
4 (2 PYRIDYL) 2,6 DIMETHYL 3,5 BIS N (PHENYL)CARBAMOYL 1,4 DIHYDROPYRIDINE;
4 (2 PYRROLYL) 2,6 DIMETHYL 3,5 BIS N (PHENYL)CARBAMOYL 1,4 DIHYDROPYRIDINE;
4 (2 PYRROLYL) 2,6 DIMETHYL 3,5 BIS N (PYRIDIN 2 YL)CARBAMOYL 1,4 DIHYDROPYRIDINE;
4 (2 THIENYL) 2,6 DIMETHYL 3,5 BIS N (PHENYL)CARBAMOYL 1,4 DIHYDROPYRIDINE;
4 (4 CHLOROPHENYL) 2,6 DIMETHYL 3,5 BIS N (PHENYL)CARBAMOYL 1,4 DIHYDROPYRIDINE;
ADENOSINE TRIPHOSPHATASE;
AMLODIPINE;
BENZBROMARONE;
DIHYDROPYRIDINE DERIVATIVE;
MULTIDRUG RESISTANCE PROTEIN 1 INHIBITOR;
PROTEIN INHIBITOR;
UNCLASSIFIED DRUG;
VERAPAMIL;
ANIMAL CELL;
ARTICLE;
CONCENTRATION RESPONSE;
CONTROLLED STUDY;
CRYSTAL STRUCTURE;
DRUG PROTEIN BINDING;
DRUG STRUCTURE;
DRUG SYNTHESIS;
DRUG TARGETING;
ENZYME ASSAY;
IC 50;
IN VITRO STUDY;
INSECT CELL;
MOLECULAR DOCKING;
NONHUMAN;
PROTEIN STRUCTURE;
STRUCTURE ACTIVITY RELATION;
ADENOSINE TRIPHOSPHATASES;
ANIMALS;
CELL LINE;
DIHYDROPYRIDINES;
DRUG RESISTANCE, MULTIPLE;
DRUG RESISTANCE, NEOPLASM;
HUMANS;
INSECTS;
P-GLYCOPROTEIN;
PROTEIN BINDING;
H. Tanabe, S. Tasaka, H. Ohmori, N. Gomi, Y. Sasaki, T. Machida, M. Iino, A. Kiue, S. Naito, and M. Kuwano Bioorg. Med. Chem. 6 1998 2219 and references cited therein
Protein Identification and Analysis Tools on the ExPASy Server
E. Gasteiger, C. Hoogland, A. Gattiker, S. Duvaud, M.R. Wilkins, R.D. Appel, and A. Bairoch Protein Identification and Analysis Tools on the ExPASy Server J.M. Walker, The Proteomics Protocols Handbook 2005 Humana Press pp 571-607
M. Bobrowska-Hägerstrand, A. Wróbel, L. Mró wczyńska, T. Söderström, Y. Shirataki, N. Motohashi, J. Molnár, K. Michalak, and H. Hägerstrand Oncol. Res. 13 2003 463